Search Within

Sarat Chandarlapaty

  1. "Clinical Cancer Research"
Formats
  1. Journal Article (11)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)
  2. Breast Medicine Service (11)
  3. Department of Medicine (11)
  4. GSK Faculty (11)
  5. Human Oncology and Pathogenesis Program (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Neal Rosen (6)
  2. Shanu Modi (4)
  3. Larry Norton (3)
  4. Sujata Patil (3)
  5. Alexia Iasonos (2)
  6. Britta Weigelt (2)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2021 (1)
  4. 2020 (2)
  5. 2014 (2)
  6. 2012 (1)

More Years

Publications
  1. Clinical Cancer Research (11)
Publishers
  1. American Association for Cancer Research (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor–positive breast cancer
    Journal Article

    Chandarlapaty, S.; Dickler, M. N.; Perez Fidalgo, J. A.; Villanueva-Vázquez, R.; Giltnane, J.; Gates, M.; Chang, C. W.; Cheeti, S.; Fredrickson, J.; Wang, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase I study of DLYE5953A, an anti-LY6E antibody covalently linked to monomethyl auristatin E, in patients with refractory solid tumors
    Journal Article

    Tolaney, S. M.; Do, K. T.; Eder, J. P.; LoRusso, P. M.; Weekes, C. D.; Chandarlapaty, S.; Chang, C. W.; Chen, S. C.; Nazzal, D.; Schuth, E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib, an AKT kinase inhibitor, as monotherapy or in combination with fulvestrant in patients with AKT1(E17K)-mutant, ER-positive metastatic breast cancer
    Journal Article

    Smyth, L. M.; Tamura, K.; Oliveira, M.; Ciruelos, E. M.; Mayer, I. A.; Sablin, M. P.; Biganzoli, L.; Ambrose, H. J.; Ashton, J.; Barnicle, A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma
    Journal Article

    Sakr, R. A.; Weigelt, B.; Chandarlapaty, S.; Andrade, V. P.; Guerini Rocco, E.; Giri, D.; Ng, C. K. Y.; Cowell, C. F.; Rosen, N.; Reis-Filho, J. S.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Molecular pathways: HER3 Targeted therapy
    Journal Article

    Gala, K.; Chandarlapaty, S.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab
    Journal Article

    Modi, S.; Stopeck, A.; Linden, H.; Solit, D.; Chandarlapaty, S.; Rosen, N.; D'Andrea, G.; Dickler, M.; Moynahan, M. E.; Sugarman, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor
    Journal Article

    Scaltriti, M.; Chandarlapaty, S.; Prudkin, L.; Aura, C.; Jimenez, J.; Angelini, P. D.; Sánchez, G.; Guzman, M.; Parra, J. L.; Ellis, C.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save